Hemovent retweeted
First experience with novel #ECMO system to meet increasing demand for #ECLS in #COVID19 #ARDS. New fully pneumatically driven device to manage resp failure safe & feasible in the series; authors suggest potential biocompatibility advantage.
@asaiojournal
https://xitter.gq/t.co/AfjsBXSeL5
BREAKING NEWS: Hemovent Gets Acquired by MicroPort and Receives Investments in Expansion of German Operations – A major milestone for Hemovent and perfect leverage for our MOBYBOX going to market. #Hemovent #Microport #MOBYBOX #ECLS #ECMO #ECPR
hemovent.com/fileadmin/conte…
BREAKING NEWS: Hemovent raises additional $5.5+ million. businesswire.com/news/home/2…
1
#Hemovent BREAKING NEWS for ECMO / ECLS USERS businesswire.com/news/home/2…
@Hemoven BREAKING NEWS: Hemovent's MOBYBOX™ "the ideal ECMO device for 'super ambulances'" businesswire.com/news/home/2…
@Hemovent BREAKING NEWS: Hemovent's MOBYBOX™ "the ideal ECMO device for 'super ambulances'" businesswire.com/news/home/2…
BREAKING NEWS: Hemovent closes $5.2M Series B financing round businesswire.com/news/home/2…
1
1
Hemovent retweeted
EOLIA trial published: Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome nejm.org/doi/full/10.1056/NE…
Latest research on ECMO at EuroELSO in Prague linkedin.com/pulse/latest-re…
Hemovent retweeted
EuroELSO is launching their new exciting webinar series on various ECMO-ECLS hot topics! Top experts in the field will be sharing their clinical experience and present latest research results on a monthly basis....
register.gotowebinar.com/reg…



















